|Emerging applications for ferumoxytol as a contrast agent in MRI|
MR Bashir, L Bhatti, D Marin, RC Nelson
Journal of Magnetic Resonance Imaging 41 (4), 884-898, 2015
|NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial|
SA Harrison, ME Rinella, MF Abdelmalek, JF Trotter, AH Paredes, ...
The Lancet 391 (10126), 1174-1185, 2018
|Gadolinium‐based contrast agents: A comprehensive risk assessment|
TJ Fraum, DR Ludwig, MR Bashir, KJ Fowler
Journal of Magnetic Resonance Imaging 46 (2), 338-353, 2017
|Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients|
V Chernyak, KJ Fowler, A Kamaya, AZ Kielar, KM Elsayes, MR Bashir, ...
Radiology 289 (3), 816-830, 2018
|Liver fat quantification using a multi‐step adaptive fitting approach with multi‐echo GRE imaging|
X Zhong, MD Nickel, SAR Kannengiesser, BM Dale, B Kiefer, MR Bashir
Magnetic resonance in medicine 72 (5), 1353-1365, 2014
|2017 version of LI-RADS for CT and MR imaging: an update|
KM Elsayes, JC Hooker, MM Agrons, AZ Kielar, A Tang, KJ Fowler, ...
Radiographics 37 (7), 1994-2017, 2017
|Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition|
JA Pietryga, LMB Burke, D Marin, TA Jaffe, MR Bashir
Radiology 271 (2), 426-434, 2014
|Evidence supporting LI-RADS major features for CT-and MR imaging–based diagnosis of hepatocellular carcinoma: a systematic review|
A Tang, MR Bashir, MT Corwin, I Cruite, CF Dietrich, RKG Do, EC Ehman, ...
Radiology 286 (1), 29-48, 2018
|Current and potential imaging applications of ferumoxytol for magnetic resonance imaging|
GB Toth, CG Varallyay, A Horvath, MR Bashir, PL Choyke, ...
Kidney international 92 (1), 47-66, 2017
|Safety and technique of ferumoxytol administration for MRI|
SS Vasanawala, KL Nguyen, MD Hope, MD Bridges, TA Hope, ...
Magnetic resonance in medicine 75 (5), 2107-2111, 2016
|Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis|
T Yokoo, SD Serai, A Pirasteh, MR Bashir, G Hamilton, D Hernando, ...
Radiology 286 (2), 486-498, 2018
|Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic …|
MS Middleton, ER Heba, CA Hooker, MR Bashir, KJ Fowler, ...
Gastroenterology 153 (3), 753-761, 2017
|Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial|
SA Harrison, MR Bashir, CD Guy, R Zhou, CA Moylan, JP Frias, ...
The Lancet 394 (10213), 2012-2024, 2019
|Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd‐EOB‐DTPA improve sensitivity and confidence for diagnosis?|
MR Bashir, RT Gupta, MS Davenport, BC Allen, TA Jaffe, LM Ho, DT Boll, ...
Journal of Magnetic Resonance Imaging 37 (2), 398-406, 2013
|Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra-and interobserver variability with manual region of interest placement versus …|
T Heye, EM Merkle, CS Reiner, MS Davenport, JJ Horvath, S Feuerlein, ...
Radiology 266 (3), 812-821, 2013
|Deep learning in radiology: An overview of the concepts and a survey of the state of the art with focus on MRI|
MA Mazurowski, M Buda, A Saha, MR Bashir
Journal of magnetic resonance imaging 49 (4), 939-954, 2019
|Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis …|
T Heye, MS Davenport, JJ Horvath, S Feuerlein, SR Breault, MR Bashir, ...
Radiology 266 (3), 801-811, 2013
|Consensus report from the 7th international forum for liver magnetic resonance imaging|
EM Merkle, CJ Zech, C Bartolozzi, MR Bashir, A Ba-Ssalamah, ...
European radiology 26 (3), 674-682, 2016
|Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy—a …|
CB Van der Pol, CS Lim, CB Sirlin, TA McGrath, JP Salameh, MR Bashir, ...
Gastroenterology 156 (4), 976-986, 2019
|NGM282 improves liver fibrosis and histology in 12 weeks in patients with nonalcoholic steatohepatitis|
SA Harrison, SJ Rossi, AH Paredes, JF Trotter, MR Bashir, CD Guy, ...
Hepatology 71 (4), 1198-1212, 2020